Becker's Healthcare August 27, 2025
The FDA has approved Pfizer and BioNTech’s updated COVID-19 vaccine for adults 65 and older along with individuals ages 5-64 who are at increased risk of severe COVID-19.
The new formulation targets several SARS-CoV-2 sublineages, aligning with the FDA guidance to better match circulating strains expected during the 2025-2026 virus season, according to an Aug....







